Aclaris Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Aclaris Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aclaris Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aclaris Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.8M | 956k | 1.90 |
| 2025-03-31 | $851k | 556k | 1.53 |
| 2024-12-31 | $1.1M | 429k | 2.48 |
| 2024-09-30 | $347k | 302k | 1.15 |
| 2024-06-30 | $1.0M | 917k | 1.10 |
| 2024-03-31 | $181k | 146k | 1.24 |
| 2023-12-31 | $547k | 521k | 1.05 |
| 2023-09-30 | $1.9M | 273k | 6.85 |
| 2023-06-30 | $4.0M | 390k | 10.37 |
| 2023-03-31 | $2.4M | 297k | 8.09 |
| 2022-12-31 | $5.5M | 347k | 15.75 |
| 2022-06-30 | $5.7M | 408k | 13.96 |
| 2022-03-31 | $4.5M | 259k | 17.24 |
| 2021-12-31 | $3.2M | 221k | 14.54 |
| 2021-09-30 | $7.9M | 441k | 18.00 |
| 2021-03-31 | $3.0M | 121k | 25.20 |
| 2020-12-31 | $170k | 26k | 6.46 |
| 2020-09-30 | $68k | 26k | 2.58 |
| 2020-06-30 | $57k | 35k | 1.62 |
| 2019-12-31 | $86k | 46k | 1.88 |
| 2019-09-30 | $46k | 42k | 1.09 |
| 2019-06-30 | $353k | 161k | 2.19 |
| 2019-03-31 | $580k | 97k | 5.99 |
| 2018-12-31 | $922k | 125k | 7.39 |
| 2018-09-30 | $1.4M | 95k | 14.52 |
| 2018-06-30 | $1.4M | 69k | 19.97 |
| 2018-03-31 | $1.7M | 99k | 17.52 |
| 2017-12-31 | $1.8M | 72k | 24.66 |
| 2017-09-30 | $6.3M | 243k | 25.81 |
| 2017-06-30 | $5.8M | 215k | 27.12 |
| 2017-03-31 | $3.9M | 130k | 29.81 |